4//SEC Filing
Benton Susan 4
Accession 0001140361-21-011672
CIK 0001228627other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:47 PM ET
Size
4.9 KB
Accession
0001140361-21-011672
Insider Transaction Report
Form 4
Benton Susan
Director
Transactions
- Award
Common Stock
2021-04-01+1,893→ 1,893 total
Footnotes (1)
- [F1]The Reporting Person was granted common stock in lieu of cash for Q1 2021 Board services. The number of shares of Common Stock having an aggregate fair market value equal to the aggregate amount of the Retainers for such fiscal quarter, determined by dividing (A) the aggregate amount of the Retainers by (B) the Fair Market Value of the Common Stock on last day of the fiscal quarter (rounded down to the nearest whole share). The Fair Market Value was $5.81 per share, the closing price of the Company's stock on March 31, 2021.
Documents
Issuer
Ocuphire Pharma, Inc.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001373649
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:47 PM ET
- Size
- 4.9 KB